Staples, J. E. Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025. European Centre for Disease Prevention and Control.
Chicago Style (17th ed.) CitationStaples, J Erin. Surveillance for Adverse Events Following Use of Live Attenuated Chikungunya Vaccine, United States, 2024, and the Associated Public Health Response in 2024 and 2025. European Centre for Disease Prevention and Control.
MLA (9th ed.) CitationStaples, J Erin. Surveillance for Adverse Events Following Use of Live Attenuated Chikungunya Vaccine, United States, 2024, and the Associated Public Health Response in 2024 and 2025. European Centre for Disease Prevention and Control.
Warning: These citations may not always be 100% accurate.